Detailed Evolutionary Analyses of the F Gene in the Respiratory Syncytial Virus Subgroup A.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
15 12 2021
Historique:
received: 08 11 2021
revised: 06 12 2021
accepted: 13 12 2021
entrez: 28 12 2021
pubmed: 29 12 2021
medline: 15 2 2022
Statut: epublish

Résumé

We performed evolution, phylodynamics, and reinfection-related antigenicity analyses of respiratory syncytial virus subgroup A (RSV-A) fusion (F) gene in globally collected strains (1465 strains) using authentic bioinformatics methods. The time-scaled evolutionary tree using the Bayesian Markov chain Monte Carlo method estimated that a common ancestor of the RSV-A, RSV-B, and bovine-RSV diverged at around 450 years ago, and RSV-A and RSV-B diverged around 250 years ago. Finally, the RSV-A F gene formed eight genotypes (GA1-GA7 and NA1) over the last 80 years. Phylodynamics of RSV-A F gene, including all genotype strains, increased twice in the 1990s and 2010s, while patterns of each RSV-A genotype were different. Phylogenetic distance analysis suggested that the genetic distances of the strains were relatively short (less than 0.05). No positive selection sites were estimated, while many negative selection sites were found. Moreover, the F protein 3D structure mapping and conformational epitope analysis implied that the conformational epitopes did not correspond to the neutralizing antibody binding sites of the F protein. These results suggested that the RSV-A F gene is relatively conserved, and mismatches between conformational epitopes and neutralizing antibody binding sites of the F protein are responsible for the virus reinfection.

Identifiants

pubmed: 34960794
pii: v13122525
doi: 10.3390/v13122525
pmc: PMC8706373
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
Epitopes 0
Viral Envelope Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Infect Dis Ther. 2014 Dec;3(2):133-58
pubmed: 25297809
PLoS Comput Biol. 2012;8(12):e1002829
pubmed: 23300419
Infect Genet Evol. 2016 Sep;43:398-406
pubmed: 27291709
Front Microbiol. 2020 Jan 15;10:3054
pubmed: 32010105
J Virol. 1999 Jan;73(1):152-60
pubmed: 9847317
Bioinformatics. 2008 Jun 15;24(12):1459-60
pubmed: 18443018
J Natl Med Assoc. 2005 Dec;97(12):1708-13
pubmed: 16396064
BMC Bioinformatics. 2010 Jul 16;11:381
pubmed: 20637083
Microorganisms. 2020 May 11;8(5):
pubmed: 32403364
Proteins. 2007 Nov 1;69(2):244-53
pubmed: 17623864
Sci Rep. 2018 Mar 14;8(1):4491
pubmed: 29540836
Immunology. 2014 May;142(1):1-23
pubmed: 24219801
Methods Mol Biol. 2014;1137:1-15
pubmed: 24573470
PLoS One. 2013 May 29;8(5):e64012
pubmed: 23734183
JAMA. 1999 Oct 20;282(15):1440-6
pubmed: 10535434
Nat Methods. 2012 Jul 30;9(8):772
pubmed: 22847109
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Electrophoresis. 1997 Dec;18(15):2714-23
pubmed: 9504803
PLoS One. 2011 Mar 01;6(3):e17427
pubmed: 21390255
J Infect Dis. 1997 Nov;176(5):1215-24
pubmed: 9359721
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9619-24
pubmed: 21586636
PLoS Comput Biol. 2014 Apr 10;10(4):e1003537
pubmed: 24722319
Front Immunol. 2018 Mar 02;9:323
pubmed: 29552008
Sci Rep. 2016 Sep 29;6:34108
pubmed: 27682426
Am J Dis Child. 1986 Jun;140(6):543-6
pubmed: 3706232
Viruses. 2018 Sep 06;10(9):
pubmed: 30200580
Infect Genet Evol. 2017 Aug;52:1-9
pubmed: 28414106
Drugs Aging. 2015 Apr;32(4):261-9
pubmed: 25851217
PLoS One. 2014 Mar 13;9(3):e90786
pubmed: 24625544
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Science. 2013 May 31;340(6136):1113-7
pubmed: 23618766
BMC Evol Biol. 2006 Jan 03;6:1
pubmed: 16388682
Pediatr Infect Dis J. 2007 Dec;26(12):1081-8
pubmed: 18043442
Virus Evol. 2018 Sep 24;4(2):vey027
pubmed: 30271623
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Sci Rep. 2019 Dec 27;9(1):20097
pubmed: 31882808
Virus Genes. 2005 Mar;30(2):267-78
pubmed: 15744582
Clin Microbiol Rev. 2017 Jan;30(1):277-319
pubmed: 27903593
Clin Infect Dis. 2013 Oct;57(8):1069-77
pubmed: 23876395
BMC Bioinformatics. 2008 Dec 02;9:514
pubmed: 19055730
Clin Infect Dis. 2010 Jul 15;51(2):185-8
pubmed: 20528472

Auteurs

Mariko Saito (M)

Gunma Prefectural Institute of Public Health and Environmental Sciences, Maebashi-shi 371-0052, Japan.

Hiroyuki Tsukagoshi (H)

Gunma Prefectural Institute of Public Health and Environmental Sciences, Maebashi-shi 371-0052, Japan.

Mitsuru Sada (M)

Department of Health Science, Gunma Paz University Graduate School, Takasaki-shi 370-0006, Japan.

Soyoka Sunagawa (S)

Department of Health Science, Gunma Paz University Graduate School, Takasaki-shi 370-0006, Japan.

Tatsuya Shirai (T)

Department of Respiratory Medicine, Kyorin University School of Medicine, Mitaka-shi 181-8611, Japan.

Kaori Okayama (K)

Department of Health Science, Gunma Paz University Graduate School, Takasaki-shi 370-0006, Japan.

Toshiyuki Sugai (T)

Division of Nursing Science, Hiroshima University, Hiroshima-shi 734-8551, Japan.

Takeshi Tsugawa (T)

Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo-shi 060-8543, Japan.

Yuriko Hayashi (Y)

Department of Health Science, Gunma Paz University Graduate School, Takasaki-shi 370-0006, Japan.

Akihide Ryo (A)

Department of Microbiology, Yokohama City University School of Medicine, Yokohama-shi 236-0004, Japan.

Makoto Takeda (M)

Department of Virology, National Institute of Infectious Diseases, Musashimurayama-shi 208-0011, Japan.

Hisashi Kawashima (H)

Department of Pediatrics, Tokyo Medical University, Shinjuku-ku 160-0023, Japan.

Nobuhiro Saruki (N)

Gunma Prefectural Institute of Public Health and Environmental Sciences, Maebashi-shi 371-0052, Japan.

Hirokazu Kimura (H)

Department of Health Science, Gunma Paz University Graduate School, Takasaki-shi 370-0006, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH